[HTML][HTML] Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
Emerging agents that target signaling pathways in cancer stem cells.
Y Yang, X Li, T Wang, Q Guo, T Xi… - Journal of Hematology & …, 2020 - europepmc.org
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
Emerging agents that target signaling pathways in cancer stem cells.
Y Yang, X Li, T Wang, Q Guo, T Xi… - Journal of Hematology …, 2020 - search.ebscohost.com
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
[PDF][PDF] Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - 2020 - scienceopen.com
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi… - Journal of Hematology …, 2020 - search.proquest.com
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
[HTML][HTML] Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi… - Journal of Hematology & …, 2020 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
Emerging agents that target signaling pathways in cancer stem cells.
Y Yang, X Li, T Wang, Q Guo, T Xi… - Journal of Hematology & …, 2020 - go.gale.com
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi… - … of hematology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
[HTML][HTML] Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo… - … of Hematology & …, 2020 - jhoonline.biomedcentral.com
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …
[PDF][PDF] Emerging agents that target signaling pathways in cancer stem cells
Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - 2020 - scholar.archive.org
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …
however, there are still no drugs targeting CSCs in clinical application. There are several …